TABLE 1 Antibodies

From: T-Cell Lymphoma Presenting in the Breast: A Histologic, Immunophenotypic and Molecular Genetic Study of Four Cases

Antibody

Source

Dilution

CD45RB(LCA)a

DAKO, Carpinteria, CA

1:200

CD20(L26)a

DAKO

1:200

CD45RO(UCHL-1)a

DAKO

1:200

CD3b,c

DAKO

1:500

CD43(MT-1)a

Biotest, Denville, NJ

1:50

βF-1(8A3)a,c

Endogen, Woburn, MA

1:50

CD30(Ber H2)a,c

DAKO

1:100

Cytokeratin(AE1/AE3)a,c

Boehringer, Indianapolis, IN

1:400

TIA-1a,d

Coulter, Miami, FL

1:400

CD4a,d

Vector (Novocastra), Burlingame, CA

1:500

ALK-1a,d

DAKO

1:100

CD8a,d

DAKO

1:100

TCR δ-1(TCR1061)a,d

Endogen

1:10

LMP-1a,c

DAKO

1:50

EMAa

DAKO

1:100

CD56a,d

Caltag, Burlingame, CA

1:100

  1. LCA, leukocyte common antigen; TIA, T-cell intracellular antigen; ALK, anaplastic lymphoma kinase; TCR, T-cell receptor; LMP, latent membrane protein; EMA, epithelial membrane antigen.
  2. Clones are in parentheses.
  3. aMouse monoclonal.
  4. bRabbit polyclonal.
  5. cRequired predigestion for 20 minutes with 0.4% Pepsin.
  6. dMicrowave antigen retrieval.